Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Y Lee

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Gut|April 15, 2003
An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndromeJ Kellow, O Y Lee, F Y Chang, et al.
The Korean Journal of Internal Medicine|January 1, 1997
Gallbladder motility change in late pregnancy and after deliveryJ S Hahm, J Y Park, S C Song, et al.
Neurogastroenterology and Motility|September 17, 2011
Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverineK J Lee, N Y Kim, J K Kwon, et al.
Neurogastroenterology and Motility|August 30, 2017
Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysisM Bashashati, S Moossavi, C Cremon, et al.
Neurogastroenterology and Motility|March 27, 2015
Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trialC H Choi, J G Kwon, S K Kim, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Gut|April 15, 2003
An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndromeJ Kellow, O Y Lee, F Y Chang, et al.
The Korean Journal of Internal Medicine|January 1, 1997
Gallbladder motility change in late pregnancy and after deliveryJ S Hahm, J Y Park, S C Song, et al.
Neurogastroenterology and Motility|September 17, 2011
Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverineK J Lee, N Y Kim, J K Kwon, et al.
Neurogastroenterology and Motility|August 30, 2017
Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysisM Bashashati, S Moossavi, C Cremon, et al.
Neurogastroenterology and Motility|March 27, 2015
Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trialC H Choi, J G Kwon, S K Kim, et al.
Pageof 2